Stocks股票 / Health Care / HAE

Haemonetics · Health Care

HAE US listed · USD美股 · 美元

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr.Haemonetics Corporation 是一家全球性的血液和血浆供应与服务提供商,由博士在马萨诸塞州纳蒂克创立。

Mid cap中盘 · $4B Rate-sensitive利率敏感 Health Care S&P 400标普400中盘
$78.17
+$0.31 · +0.40%
52w low52周低 $46.74high $88.33
Lagging — relative weakness落后 — 相对弱势 The daily turn is in off a real pullback, but the cycle count is stretched well past its usual window — so this is an UNCONFIRMED new cycle, not a fresh low…日线已在一次真实回调后转向,但周期天数已远超通常窗口——因此这是未确认的新周期,尚非全新低点。请在确认后买入(更高的低点 + 周线转向),而非此处。 Engine read引擎解读 · 2026-07-21

Price chart价格图表

daily · interactive日线 · 可交互 Open in Terminal打开终端
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。 Open the live chart in Terminal在终端中打开实时图表
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。 MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动

Technicals技术面

daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量(RSI 14) 62
Elevated偏高
vs 50-day average相对50日均线 +11.8% above上方 Uptrend intact趋势完好
vs 200-day average相对200日均线 +18.1% above上方 Long trend up长期向上
Volatility波动率 52th percentile第52百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源,每晚更新。

Earnings财务业绩

next report下次财报 2026-08-06
17days to go天后公布

Estimates being cut预期下调

Valuation估值

Roughly fair vs sector相对行业估值合理
Multiple指标HAE Sector median行业中位Cheaper than相对便宜
P/E (trailing)市盈率(历史) 37.62x 28.59 32%
P/B市净率 4.02x 3.44 41%
P/S市销率 2.74x 2.97 54%
Earnings yield盈利收益率 2.66% 2.72 49%
FCF yield自由现金流收益率 3.89% 4.00 48%
Shareholder yield股东收益率 4.78% 1.89 83%
EV/EBITDA企业价值/EBITDA 13.57x 18.18 72%
P/FCF市值/自由现金流 25.70x 22.08 39%
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。

Financials财务数据

fiscal years财年
Revenue营业收入
$870.5M2021
$993.2M2022
$1.2B2023
$1.3B2024
$1.4B2025
5-yr growth5年复合增速 11.8%
Earnings per share每股收益
$1.552021
$0.842022
$2.242023
$2.292024
$3.312025
5-yr growth5年复合增速 20.9%
Free cash flow自由现金流
$71.8M2021
$75.8M2022
$162.9M2023
$115.5M2024
$142.4M2025
Gross margin毛利率
59.0%
Operating margin营业利润率
16.3%
Net margin净利率
7.3%
FCF margin自由现金流利润率
22.0%
Balance-sheet quality财务体质 6/9 Bankruptcy risk: grey zone破产风险:灰色区 Return on equity股本回报率 11% Clean稳健

Leverage杠杆

Net debt / EBITDA净债务/EBITDA2.72
Current ratio流动比率1.62

Capital allocation资本配置

Stock-based comp股权薪酬$29.6M
Share count change (1y)股数变化(1年)-6.8%

Why is it moving为何波动

6 checks · nightly六项检查 · 每晚
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 BOTTOMING → NEARING A HIGH筑底中 → 接近高点

Ownership & smart money持仓与聪明钱

13F

Insider activity:内部人动向: +$0.1M net (1 buyers, 0 sellers)+$0.1M 净值(1 买家,0 卖家)

Signal history信号历史

engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中 BUY SETUP. A new cycle low likely formed 19 day(s) ago (2026-06-22 @ 72.53): swing low in, price back above the 10-day average — but the weekly timeframe hasn't turned yet, so conviction is partial. Last cycle was left-translated (topped early) — a bearish structural tell买入预备。新的周期低点可能已在 19 天前形成 (2026-06-22 @ 72.53):摆动低点已现,价格重新站上 10 日均线——但周线周期尚未转向,因此信心仅为部分。 上一周期为左移结构(见顶偏早)——属于看空的结构性信号
Jul 15, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 15, 2026
HAE took relative-strength leadershipHAE 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $76.68.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$76.68。
Jul 13, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 10, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 10, 2026
HAE took relative-strength leadershipHAE 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $76.19.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$76.19。
Jul 10, 2026
HAE StochRSI turned up from oversoldHAE StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $76.19.StochRSI重回20上方 — 下行动量趋缓的最早预警。$76.19。
Jul 7, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
HAE took relative-strength leadershipHAE 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $75.07.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$75.07。
Jun 29, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jun 26, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jun 26, 2026
HAE StochRSI turned up from oversoldHAE StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $77.29.StochRSI重回20上方 — 下行动量趋缓的最早预警。$77.29。
Showing the last 15 of显示最近15条,共 239 signals条信号

Company profile公司档案

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr.Haemonetics Corporation 是一家全球性的血液和血浆供应与服务提供商,由博士在马萨诸塞州纳蒂克创立。

Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Below market低于市场

The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。

Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。

Browse all stocks浏览所有股票 Open Terminal打开终端

Research context only — not investment advice. Past patterns do not guarantee future results.仅供研究参考,不构成投资建议。历史规律不代表未来表现。

Data through数据截至 2026-07-21 · regenerated nightly每晚更新 · Generated生成于 2026-07-21 02:08 UTC · All coverage所有股票 · Analyzer分析器